Incidence of sentinel node metastasis in patients with thin primary melanoma (≤1 mm) with vertical growth phase

Annals of Surgical Oncology

Volumn 7, Issue 4, 2000, Pages 262-267

  Bedrosian, Isabelle ^a   Faries, Mark B ^a   Guerry IV, DuPont ^a   Elenitsas, Rosalie ^a   Schuchter, Lynn ^a   Mick, Rosemarie ^a   Spitz, Francis R ^a   Bucky, Louis P ^a   Alavi, Abass ^a   Elder, David E ^a   Fraker, Douglas L ^a   Czerniecki, Brian J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Metastasis; Sentinel node; Thin melanoma; Vertical growth phase

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; FEMALE; GROWTH CURVE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; RISK FACTOR; SURVIVAL RATE; THICKNESS; TUMOR VOLUME;

EID: 0034036053     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0262-z     Document Type: Article

References (25)

1. Slingluff CL, Seigler H. Melanoma. In: Sabiston DCJ, ed. Textbook of Surgery: The Basis of Modern Surgical Practice. 15th ed. Philadelphia: W.B. Saunders, 1997:515-28.
2. Rigel D, Friedman R, Kopf A. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996;34:839-47.
3. Consensus Statement. Diagnosis and treatment of early melanoma. NIH Consensus Development Conference January 27-29, 1992.
4. Kelly JW, Sagebiel RW, Clyman S, Blois MS. Thin level IV malignant melanoma: a subset in which level is the major prognostic indicator. Ann Surg 1985;202:98-103.
5. Naruns PL, Nizze JA, Cochran AJ, Lee MB, Morton DL. Recurrence potential of thin primary melanomas. Cancer 1986;57:545-8.
6. Shaw HM, McCarthy WH, McCarthy SW, Milton GW. Thin malignant melanomas and recurrence potential. Arch Surg 1987; 122:1147-50.
7. Slingluff CL Jr, Vollmer RT, Reintgen DS, Seigler HF. Lethal, "thin" malignant melanoma. Ann Surg 1988;208:150-61.
8. Woods JE, Soule EH, Creagan ET. Metastasis and death in patients with thin melanoma (less than 0.76 mm). Ann Surg 1983;198: 63-4.
9. Clark W Jr, Elder D, Guerry IV D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-1904.
10. Szymik B, Woosley J. Further validation of the prognostic model for stage I malignant melanoma based on tumor progression. J Cutan Pathol 1993;20:50-3.
11. Clark WH Jr, Elder DE, Guerry D IV, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15:1147-65.
12. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest 1987;56:461-74.
13. Guerry D IV, Synnestvedt M, Elder D, Schultz D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol 1993;100:342S-5S.
14. Straume O, Akslen L. Independent prognostic importance of vascular invasion in nodular melanomas. Cancer 1996;78:1211-9.
15. Johnson OJ, Emrich L, Karakousis C, Rao U, Greco W. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical stage I. Cancer 1985;55:1107-17.
16. Herlyn M, Balaban G, Bennicelli J, et al. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst 1985;74:283-9.
17. Elder D, Rodeck U, Thurin J, et al. Antigenic profile of tumor progression stages in human melanocytic nevi and melanoma. Cancer Res 1989;49:5091-6.
18. Rak J, Hegmann E, Lu C, Kerbel R. Progressive loss of sensitivity to endothelium derived growth inhibitors expressed by human melanoma cells during disease progression. J Cell Physiol 1994; 159:245-55.
19. Wanebo HJ, Cooper PH, Hagar RW. Thin (<1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg 1985;201:499-504.
20. Gromet M, Epstein W, Blois M. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer 1978;42:2282-92.
21. Paladugu R, Yonemoto R. Biologic behavior of thin malignant melanoma with regressive changes. Arch Surg 1983;118:41-4.
22. Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK. Thin malignant melanomas with regression and metastases. Arch Dermatol 1987;123:1326-30.
23. McCarthy W, Shaw H, McCarthy S, Rivers J, Thompson J. Cutaneous melanomas that defy conventional prognostic indicators. Semin Oncol 1996;23:709-13.
24. Krag D, Meijer S, Weaver D, et al. Minimal access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
25. McDermott N, Hayes D, al-Sader M, et al. Identification of vertical growth phase in malignant melanoma: a study of interobserver agreement. Am J Clin Pathol 1998;110:753-7.